ALS Therapy Development Institute

The ALS Therapy Development Institute (ALS TDI) is a nonprofit organization dedicated to finding effective treatments for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. Founded in 1999, ALS TDI conducts research and drug development specifically targeting ALS. The institute collaborates with scientists, clinicians, and the ALS community to accelerate the discovery of potential therapies. Utilizing a unique model that emphasizes collaboration and transparency, ALS TDI focuses on preclinical studies and clinical trials to bring promising treatments to patients faster, ultimately aiming to improve the quality of life for those affected by ALS.